Nebulized fentanyl for respiratory symptoms in patients with COVID-19 (ventanyl trial)
<p dir="ltr">Patients with coronavirus disease (COVID-19) commonly experience distressing and challenging respiratory symptoms. Interventions such as oxygen therapy, oral opiates, and traditional nebulizers like ipratropium bromide and salbutamol are variable in their efficacy, and t...
Saved in:
| Main Author: | Nissar Shaikh (11659441) (author) |
|---|---|
| Other Authors: | Mohamad Y. Khatib (11659459) (author), Mohammad A. Al Wraidat (21322907) (author), Ahmed S. Mohamed (11659456) (author), Anood A. Al-Assaf (21322910) (author), Abdul Gafoor M. Tharayil (21322913) (author), Ahmad A. Abujaber (14586054) (author), Abdulqadir J. Nashwan (11659453) (author) |
| Published: |
2022
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Can we use normal saline stored under stress conditions? A simulated prehospital emergency medical setting
by: Ousama Rachid (14158917)
Published: (2023) -
The impact of chronic fentanyl administration on the cerebral cortex in mice: Molecular and histological effects
by: Ayman Alzu'bi (18192898)
Published: (2024) -
Application of Li-, Mg-, Ba-, Sr-, Ca-, and Sn-doped ceria for solar-driven thermochemical conversion of carbon dioxide
by: Gorakshnath Takalkar (14151135)
Published: (2022) -
Trans-resveratrol-loaded nanostructured lipid carrier formulations for pulmonary drug delivery using medical nebulizers
by: Iftikhar, Khan
Published: (2025) -
Inhalational injury and use of heparin & N-acetylcysteine nebulization: A case report
by: Nissar Shaikh (11659441)
Published: (2022)